Steven Lawrence, MD
Gastroenterology · Littleton, CONPI 1487641106
Payments from drug & device makers
Across 479 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$928
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$901
- Johnson & Johnson$894
- Gilead$735
- Bristol Myers Squibb$531
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$631%
- Food & beverage$8,91296%
- Education$3514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 136 | $2,656 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $928 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 52 | $901 |
| Johnson & Johnson(2 entities) | 40 | $894 |
| Gilead | 35 | $735 |
| Bristol Myers Squibb | 34 | $531 |
| Regeneron Healthcare Solutions, Inc. | 19 | $379 |
| Intercept Pharmaceuticals, Inc. | 16 | $355 |
| Pfizer | 16 | $277 |
| Sanofi | 10 | $234 |
| QOL Medical, LLC | 13 | $222 |
| Lilly USA, LLC | 8 | $174 |
| Celltrion USA Inc. | 7 | $137 |
| UCB, Inc. | 4 | $86 |
| Ardelyx, Inc. | 3 | $83 |
| AstraZeneca | 5 | $78 |
| Ferring Pharmaceuticals Inc. | 4 | $64 |
| Aimmune Therapeutics, Inc. | 1 | $63 |
| Nestle Healthcare Nutrition Inc. | 4 | $60 |
| Ironwood Pharmaceuticals, Inc | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Shionogi Inc | 3 | $46 |
| Redhill Biopharma Inc. | 3 | $45 |
| Medtronic | 1 | $34 |
| Echosens North America, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $24 |
| Shire North American Group Inc | 1 | $24 |
| Cook Medical LLC | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Romark Laboratories, LC | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,326 in reported general payments places this provider in the 75th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 25 | $6,857 |
| Colesevelam Hcl | 18 | $2,215 |
| Omeprazole | 128 | $1,843 |
| Budesonide DrBudesonide | 12 | $850 |
| Pantoprazole Sodium | 59 | $828 |
| Rabeprazole Sodium | 12 | $730 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $235 |
| Esomeprazole Magnesium | 11 | $129 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Littleton
- Bahri BilirLittleton$502K
- Erik SpringerLittleton$143K
- Bhaktasharan PatelColorado Springs$22M
- Marcelo KugelmasEnglewood$2.7M
- Douglas AdlerColorado Springs$1.2M
- Masi KhajaGrand Junction$1.2M
- Peter McNallyFt Carson$1.1M
- Mark GerichAurora$1M
- Raj ShahAurora$764K
- Rajesh JainLakewood$708K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.